Publikationer

Artikler udgået fra Dansk Kolinesterase Kartotek (1990-2007)

Gätke MR, Bundgaard JR, Viby-Mogensen J. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. Pharmacogenetics and Genomics 2007, 17:995-999 (download pdf file)

Gätke MR, Østergaard D, Viby-Mogensen J, Rasmussen SN, Skovgaard LT. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: Effect of injektion of human cholinesterase. Anesthesiology 2005; 102:1124-1132 (download pdf file)

Gätke MR, Viby-Mogensen J, Østergaard D, Bundgaard JR. Response to mivacurium in patients carrying the K-variant in the butyrylcholinesterase gene. Anesthesiology 2005;102:503-8 (download pdf file)

Viby-Mogensen J. Anesthesiology, the birth of pharmacogenetics and Werner Kalow. Can J Anesth 2004; 51:3; 197-200 (download pdf file)

Østergaard D, Viby-Mogensen J, Rasmussen SN, Gätke MR, Pedersen Na, Skovgaard LT. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variant (UA). Acta Anaesthesiol Scand 2003;47:1219-25 (download pdf file)

Østergaard D, Viby-Mogensen J, Pedersen NA, Holm H, Skovgaard LT. Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients. Acta Anaesthesiol Scand 2002;46:684-91 (download pdf file)

Østergaard D, Ibsen M, Skovgaard LT, Viby-Mogensen J. Plasma cholinesterase activity and duration of action of mivacurium in phenotypically normal patients. Acta Anaesthesiol Scand 2002;46:679-83 (download pdf file)

Østergaard D, Gätke MR, Berg H, Rasmussen SN, Viby-Mogensen J. The pharmacodynamics and pharmacokinetics of mivacurium in children. Acta Anaesthesiol Scand 2002;46:512-8 (download pdf file)

Gätke MR, Østergaard D, Bundgaard JR, Viby-Mogensen J. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene. Anesthesiology 2001;95:600-6 (download pdf file)

Østergaard D, Rasmussen S.N. Viby-Mogensen J, Pedersen, N.A., Boysen, R. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium. Anesthesiology 2000;92:1581-7

Jensen FS, Gätke MR, Østergaard D, Bundgaard JR, Viby Mogensen J. Mutationer i plasmakolinsterasegenet og anæstesi. Information fra Dansk Kolinesterase Kartotek. Ugeskr Læger 2000;162:161-2

Bang U, Nyberg L, Rosenborg J, Viby-Mogensen J. Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase. Br J Clin Pharmacol 1998;45:479-84

Jensen FS, Viby Mogensen J. Plasmakolinesterase og unormale reaktion på injektion af suxamethon. Tyve års erfaring med Dansk Kolinesterase Kartotek. Ugeskr Læg 1996;158:1835-9

Jensen FS. Plasma kolinesterase og unormal reaktion på injektion af suxameton: tyve års erfaringer med Dansk Kolinesterase Kartotek. Ugeskr Læger. 1996 (Parallelpublikation)

Jensen FS, Nielsen LR, Schwarts M. Detection of the plasma cholinesterase K variant by PCR using Amplification-Created Restriction Site. Human Hered 1996;46:26-31

Østergaard D, Jensen FS, Viby-Mogensen J. Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. Anesthesiology 1995;82:1295-8

Jensen FS, Skovgaard LT, Viby-Mogensen J. Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis. Acta Anaesthesiol Scand 1995;39:157-62

Jensen FS, Viby-Mogensen J. Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years’ experience with the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand 1995;39:150-6

Østergaard D, Jensen FS, Skovgaard LT, Viby-Mogensen J. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity. Acta Anaesth Scand 1995;39:1016-8

Østergaard D, Jensen FS, Viby-Mogensen J. Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. Anesthesiology 1995;82:1295-8

Østergaard D, Viby-Mogensen J. The significance of plasma cholinesterase for the pharmacokinetics and pharmacodynamics of mivacurium. Anaesthetic Pharmacology Review 1995;3:176-81

Jensen FS, Schwartz M, Viby-Mogensen J. Identification of human plasma cholinesterase variants using molecular biological technique. Acta Anaesthesiol Scand 1995;39:142-9

Pedersen NA, Jensen FS. The clinical importance of plasma cholinesterase for the anaesthetist. Ann Acad Med Singapore 1994;23 (suppl.):120S-4S

Jensen FS, Østergaard D. Cholinesterases. Cur Opin Anaesth 1993;6:730-4

Goudzouzian NG, d’Hollander AA, Viby-Mogensen J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993;77:183-5

Østergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J. Mivacurium-induced neuromuscular blockade in patients with atypical plasma choline­sterase. Acta Anaesthesiol Scand 1993;37:314-8

Goudsouzian NG, d'Hollander AA, Viby-Mogensen J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993;77: 183-5

Bartels CF, Jensen FS, Lockridge O, van der Spek AFL, Rubinstein HM, Lubrano T, la Du BN. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992;50:1086-1103

Jensen FS, Bartels CF, la Du BN. Structural basis of the butyrylcholinesterase H-variant segregating in two Danish families. Pharmacogenetics 1992;2:234-40

Jensen FS, Viby-Mogensen J. Reaction to succinylcholine in two patients segregating for the plasma cholinesterase allele Ek.. Acta Anaesthesiol Scand 1992;36:753-7

Østergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscu­lar blockade in phenotypically normal patients. Acta Anaesth Scand 1992;36:702-6

Jensen FS, Viby-Mogensen J, Østergaard D. Significance of plasma cholinesterase for the anaesthetist. Curr Anaesth Crit Care 1991;2:232-7

Jensen FS, Viby-Mogensen J. Anaesthesia and abnormal plasma cholinesterase. In: Cholinesterases: Structure, function, mechanism, genetics, and cell biology. Massou­lié J et al. eds. American Chemical Society, 1991, pp. 336-8

Østergaard D, Viby-Mogensen J, Hanel HK, Theil Skovgaard L. Pretreatment with pancuronium before suxamethonium administration in patients hetero­zygous for the usual and the atypical plasma cholinesterase gene. Acta Anaesthesiol Scand 1991;35:502-7

Tunek A, Hjertberg E, Viby-Mogensen J. Interactions of Bambuterol with human serum cholinesterase of the genotypes E^uE^u (normal), E^aE^a (atypical) and E^uE^a. Biochemical Pharmacology 1991; 41:345-48

Bang U, Viby-Mogensen J, Wirén JE. The effect of Bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Acta Anaesthesiol Scand 1990;34:600-4

Bang U, Viby-Mogensen J, Wirén JE, Skovgaard LT. The effect of Bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients. Acta Anaesthesiol Scand 1990;34:596-9

Østergaard D, Viby-Mogensen J. Pseudocholinesterase deficiency. I: Handbook of clinical anesthesia. Goldstone JC & Pollard BJ (eds.), Churchill Livingstone, 1996, p. 660-2 og 2003 p. 784-6

Østergaard D, Jensen FS, Viby-Mogensen J. Pseudocholinesterase deficiency and anticholinesterase toxicity. In: Clinical and Experimental Toxicology of Organophosphates and Carbamates. Eds. Ballantyne & TC Marrs, Butterworth Heinemann 1992, pp. 520-7

1. Viby-Mogensen J. Mivacurium block in patients with abnormal plasma cholinesterase. Acta Anaesthesiol Scand 1995;39:1001-2